Last reviewed · How we verify
NCT07138768
Role of MRI in the Early Diagnosis and Management of Acute Stroke and Its Impact on Turnaround Time in Emergency Settings
trial testing Magnetic Resonance Imaging in Magnetic Resonance Imaging in 136 participants. Currently enrolling.
1 December 2026
Quick facts
| Lead sponsor | Tanta University |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 136 |
| Start date | 23 August 2025 |
| Primary completion | 1 December 2026 |
| Estimated completion | 1 December 2026 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- Magnetic Resonance Imaging
Conditions studied
- Magnetic Resonance Imaging — all drugs for Magnetic Resonance Imaging →
- Diagnosis — all drugs for Diagnosis →
- Management — all drugs for Management →
- Acute Stroke — all drugs for Acute Stroke →
Sponsor
Tanta University
Who can join
18 and older, any sex, with Magnetic Resonance Imaging or Diagnosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to evaluate the role of stroke protocol in the early diagnosis and management of acute stroke and its effect on turnaround time (TAT) in emergency settings.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07138768
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Magnetic Resonance Imaging
Trials testing the same drug.
- NCT03192007 — Multi-Parametric MRI for Renal Transplantation · not yet recruiting
- NCT07229339 — Zipalertinib With Carboplatin and Pemetrexed for the Treatment of Resectable, Stage II-IIIB, Non-Small Cell Lung Cancer · Phase 2 · not yet recruiting
- NCT07441681 — Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive · Phase 3 · not yet recruiting
- NCT07147231 — Testing the Effectiveness of the Anti-cancer Drug Pidnarulex (CX-5461), in Combination With Another Anti-cancer Drug Cem · Phase 1, PHASE2 · recruiting
- NCT06448286 — PH Weighted Chemical Exchange Saturation Transfer MRI-Based Surgical Resection to Improve Survival in Patients With Glio · Phase 3 · not yet recruiting
Other recruiting trials for Magnetic Resonance Imaging
Currently open trials in the same condition.
- NCT06725550 — Integrative Medicine in Pain Management in Sickle Cell Disease, 2.0 · NA · recruiting
- NCT07069452 — Prognostic Value of Isolated and Combined Score Aspects in Acute Ischemic Stroke · recruiting
- NCT06509087 — The Combined Utility of Angio-CT and MRI in Managing Chronic Musculoskeletal Pain: a Prospective Study to Evaluate the E · recruiting
- NCT06108089 — Novel Hypoxia Imaging for Head and Neck Cancer: Imaging Phenotype for Personalized Treatment · recruiting
- NCT06467045 — Frequency of Adverse Events in Pediatric Patients Receiving Sedation for Magnetic Resonance Imaging · recruiting
Other Tanta University trials
Trials by the same sponsor.
- NCT07398651 — Apremilast and Adalimumab in Psoriatic Arthritis Patients · NA · not yet recruiting
- NCT06966856 — This Randomized, Clinical Trial Evaluates the Efficacy of Oral Versus Sublingual Vitamin B12 Supplementation in Correcti · Phase 3 · not yet recruiting
- NCT07334197 — Effect of Melatonin on Left Ventricular Reverse Remodeling and Inflammation in Peripartum Cardiomyopathy · NA · not yet recruiting
- NCT07498998 — Glucocorticoid, Ozone and 5% Dextrose Local Injection for Pain Relief in Carpal Tunnel Syndrome · NA · not yet recruiting
- NCT07114250 — Comparative Study Between Spinal Anesthesia Versus General Anesthesia in Supine Percutaneous Nephrolithotomy Operation · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07138768 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Tanta University
- Last refreshed: 26 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07138768.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing